Project Grant R01NS147962
- Federal Grant Award Summary Award Details: Dartmouth College received a $1,010,880 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) effective May 1, 2026, through April 30, 2029. The award supports the translation of a novel carbon-coating technology for integrated neurotransmitter sensing in humans. Products and Services: The project delivers the...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded $336,935 to the University of California, Los Angeles under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on August 1, 2025, for a project period extending through July 31, 2027. The primary deliverable is the development and technical refinement of dual in vivo whole-cell and large-scale extracellular Neuropixels recording techniques in awake...
- Federal Grant Award Summary New York University School of Medicine received a $381,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on August 4, 2025, with a completion date of July 31, 2027. This award funds the development of genetic strategies to study a novel disinhibitory system in the neocortex, specifically...
- Federal Project Grant Award Summary New York University School of Medicine received a $141,102 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), effective September 1, 2025 through August 31, 2027. The project, titled "Astrocyte Network Facilitation of Neuroplasticity," delivers research focused on understanding...
- Federal Grant Award Summary Vanderbilt University received a $557,161 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on July 10, 2026. The three-year project, scheduled for completion by June 30, 2029, focuses on developing a novel Bioluminescence Resonance Energy Transfer (BRET) system for optimizing and imaging in vivo recording of neural...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University $616,585 on May 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop tools enabling brain-wide chronic electrophysiology recording in freely moving rodents. The project, spanning five years through April 30, 2031, addresses critical technical barriers associated with the emerging...
- Federal Cooperative Agreement Award Summary Cornell University's Office of Sponsored Programs received a $686,023 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), effective July 8, 2026, through June 30, 2030. The award supports research led by Principal Investigator Chris Xu and co-investigators Frank Wise and Nilay Yapici to develop...
- The Regents of the University of Michigan received a $137,586 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant funds the development of a reconfigurable neural interface platform that can integrate multiple sensor modalities, including electrophysiological recording, neurostimulation, and physiochemical...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB), under its Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded $594,533 to the University of Colorado Boulder (Project Grant, awarded May 1, 2026, completion April 30, 2029) to develop novel magnetic nanotransducers for non-invasive neural stimulation. The project addresses a critical clinical need by creating nanoparticles...
- Federal Project Grant Award Summary New York University received a $224,100 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) to conduct fundamental neuroscience research on visual information processing in spatial memory circuits. The project, which began on September 30, 2025, and will conclude on September 29, 2028,...
Grant Award Summary Columbia University received a $462,148 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on July 8, 2026, with a completion date of June 30, 2029. The award funds development and benchmarking of functional graphene nanoribbon (F-GNR) neural probes designed to enable high-resolution, ion-selective multimodal brain mapping. The project delivers advanced neurotechnology tools capable of detecting specific ionic signals—such as sodium and potassium ions—with unprecedented spatiotemporal resolution and biological stability, addressing a significant gap in current neuroimaging capabilities. The grant supports three primary deliverables: development and benchmarking of F-GNR-based neural probes for ion-selective, multimodal signal detection in biologically relevant laboratory models; demonstration of in vivo recording of dynamic ionic signals in behaving animals; and validation of probe performance in disease-relevant animal models. These functional neural probes combine electrical conductivity and optical detection modalities in a scalable platform, with preliminary evidence demonstrating high sensitivity to neural action potentials, biocompatibility lasting weeks, and spatial-temporal resolution sufficient to monitor individual neurons. Upon completion, the technology is expected to enable new insights into how specific ionic fluxes regulate neural circuit activity and behavior.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $462.1k | 7/8/26 |